window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Sofinnova Partners

  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Novartis agrees $1.5bn Myricx Bio acquisition to strengthen ADC pipeline

    Novartis has agreed to acquire UK biotech Myricx Bio for [...]

    July 6, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Bionyra launches with $165M Series A to advance immunology biologics pipeline

    bionyra-pharma-series-a-immunology Bionyra Pharma has launched with a $165 million Series [...]

    June 22, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Ingenix raises €13M to expand AI platform for drug development

    Poland-based AI drug development company Ingenix has raised €13 million [...]

    June 8, 2026
  • Biotech & Pharma Business,Pharmaceuticals and therapeutics

    Sofinnova Partners closes €650m Capital XI to back early-stage healthcare deals

    Sofinnova Partners, a European life sciences venture capital firm with [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory

    NanoPhoria secures €83.5m Series A in largest-ever Italian biotech raise to advance heart failure therapy

    NanoPhoria Bioscience has completed an €83.5 million Series A financing [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Therapeutic Areas

    eXmoor and Signadori Bio partner to advance monocyte-based cell therapy for solid tumours

    New alliance focuses on translation, process development and GMP-readiness for [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Sofinnova Partners and NVIDIA join forces to boost European AI in life sciences

    Sofinnova Partners has announced a new collaboration with NVIDIA to [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FDA grants Fast Track status to SOTIO’s colorectal cancer ADC ahead of Phase 1/2 trial
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • EpilepsyGTx partners with ClearPoint Neuro to support Phase 1 gene therapy trial
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Delivery & Formulation, Research & Development
  • Skyhawk expands global Huntington’s disease trial following positive Phase 1/2 data
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top